Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TCR-800 by T-Cure Bioscience for Metastatic Renal Cell Carcinoma: Likelihood of Approval
TCR-800 is under clinical development by T-Cure Bioscience and currently in Phase I for Metastatic Renal Cell Carcinoma. According to...